A. de Diego Damiá

ORCID: 0000-0002-8371-0141
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Asthma and respiratory diseases
  • Respiratory and Cough-Related Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Inhalation and Respiratory Drug Delivery
  • Medical research and treatments
  • Pediatric health and respiratory diseases
  • Renal function and acid-base balance
  • Gastroesophageal reflux and treatments
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Neonatal Respiratory Health Research
  • Delphi Technique in Research
  • Medical Imaging and Pathology Studies
  • Tracheal and airway disorders
  • Heart Rate Variability and Autonomic Control
  • Allergic Rhinitis and Sensitization
  • Neuroscience of respiration and sleep
  • Autoimmune and Inflammatory Disorders Research
  • Health, psychology, and well-being
  • Voice and Speech Disorders
  • COVID-19 Clinical Research Studies
  • Parvovirus B19 Infection Studies
  • Cystic Fibrosis Research Advances
  • Heart Failure Treatment and Management
  • Lung Cancer Diagnosis and Treatment

Hospital Universitari i Politècnic La Fe
2011-2024

University Hospital Galway
2023

Holy Cross Hospital
2021-2022

Biogipuzkoa Health Research Institute
2020

Center for Rheumatology
2018

Sociedad Española de Neumología y Cirugía Torácica
2010

Hospital General Universitario De Valencia
2009-2010

Instituto de Ciencias de La Construcción Eduardo Torroja
2010

Universitat de València
1991-2005

Service de la Santé Publique
1997

The impact of blood eosinophilia in chronic obstructive pulmonary disease (COPD) remains controversial. To evaluate the prevalence and stability a high level eosinophils (≥300 cells·μL –1 ) its relationship to outcomes, we determined at baseline over 2 years 424 COPD patients (forced expiratory volume 1 s (FEV 60% predicted) 67 smokers without from CHAIN cohort, 308 BODE cohort. We related eosinophil levels exacerbations survival using Cox hazard analysis. In patients, 15.8% cohort 12.3% had...

10.1183/13993003.01162-2017 article EN European Respiratory Journal 2017-11-01

Pulmonary hypertension in idiopathic pulmonary fibrosis (IPF) is indicative of a poor prognosis. Recent evidence suggests that tetrahydrobiopterin (BH4), the cofactor nitric oxide synthase (NOS), involved and artery endothelial-to-mesenchymal transition (EnMT) may contribute to fibrosis. However, role BH4 remodelling secondary unknown. This study examined system plasma arteries from patients with IPF as well antiremodelling antifibrotic effects precursor sepiapterin rat bleomycin-induced...

10.1136/thoraxjnl-2013-203408 article EN Thorax 2013-06-05

Patients with chronic obstructive pulmonary disease (COPD) often suffer episodes of exacerbation (ECOPD) that impact negatively the course their disease. ECOPD are heterogeneous events unclear pathobiology and non-specific diagnosis. Network analysis is a novel research approach can help unravelling complex biological systems. We hypothesised comparison multi-level ( i.e. , clinical, physiological, biological, imaging microbiological) correlation networks determined during convalescence...

10.1183/13993003.00075-2017 article EN European Respiratory Journal 2017-09-01

To explore the effect of long-term therapy with azithromycin in regards to airway oxidative stress markers exhaled breath condensate (EBC) adult patients stable non-cystic fibrosis (CF) bronchiectasis.Open-label prospective study 30 randomized 250 mg three times per week during 3 months (16 patients) or control (14 patients). Primary outcome were changes nitric oxide, 8-isoprostane, pH, nitrites and nitrates EBC. Secondary outcomes exacerbation rates, dyspnoea (Borg scale), sputum volume...

10.1111/resp.12130 article EN Respirology 2013-05-29

Abstract Purpose Chronic cough (cough that persists for ≥ 8 weeks) can cause a range of physical symptoms and psychosocial effects significantly impair patients’ quality life. Refractory chronic (RCC) unexplained (UCC) are challenging to diagnose manage, with substantial economic implications healthcare systems. Methods This retrospective multicenter non-interventional study aimed characterize the profile health resource consumption patients RCC or UCC who attended outpatient clinics at...

10.1007/s00408-023-00620-y article EN cc-by Lung 2023-05-09

10.1007/s100960000294 article EN European Journal of Clinical Microbiology & Infectious Diseases 2000-07-04

Background: Mechanisms underlying cough and bronchoconstriction in patients with cough‐variant asthma (CVA) are not well established. Differences location or degree of activation eosinophils allergic cytokines have been suggested as the likely causes. To address this issue, we carried out a comparative study airway inflammatory markers between CVA classic (CA). The relationship these hyperresponsiveness (AHR) sensitivity has also studied. Methods: Twenty‐seven non‐smokers steroid‐naive (12)...

10.1111/j.1398-9995.2005.00609.x article EN Allergy 2005-10-03

Inhaled corticosteroid (ICS) with long-acting beta-2 agonists is a well-documented combination therapy for chronic obstructive pulmonary disease (COPD) based on its additive anti-inflammatory properties. By contrast, the recommendation of ICS in muscarinic antagonist (LAMA) not evidence-based. In this study, neutrophils obtained from COPD patients were used to compare effects aclidinium bromide (a antagonist) corticosteroids and their potential effect. Human sputum blood isolated healthy...

10.1186/s12931-016-0467-8 article EN cc-by Respiratory Research 2016-11-08

This study has a twofold objective: 1) to explore what extent suffering from asthma affects the HRQL of men and women differently at several stages disease severity 2) analyze whether informed poorer asthmatic is related their higher scores on instruments measuring emotionally disordered symptoms. One hundred fifty‐one outpatient asthmatics (84 67 men) completed Spanish versions Asthma Quality Life questionnaire (AQL), as well anxiety depression inventories. A full history, physical...

10.1081/jas-120024595 article EN Journal of Asthma 2003-01-01

Dyspnea is a main feature of symptomatology in asthma, and its perception does not necessarily correlates well with airway obstruction. The aim this study was twofold: Citation to identify factors determining the subjective degree dyspnea patients different grades stable bronchial asthma compare various clinical methods existing for grading dyspnea. investigation comprised 153 outpatients asthma. parameters studied were following: demographic characteristic subjects, baseline score by means...

10.1081/jas-120018637 article EN Journal of Asthma 2003-01-01

Abstract Background The loss of corticosteroid efficacy is an important issue in severe asthma management and may lead to poor control deterioration airflow. Recent data indicate that Mucin 1 ( MUC 1) membrane mucin can mediate chronic rhinosinusitis, but the role uncontrolled unknown. objective was analyze previously unexplored on asthma. Methods expression evaluated by real‐time PCR human bronchial epithelial cells HBEC ) blood neutrophils from (n = 27), controlled mild 16), healthy...

10.1111/all.13546 article EN Allergy 2018-07-06

Non-T2 severe asthma and chronic obstructive pulmonary disease (COPD) are airway inflammatory disorders with a poor response to corticosteroids. LAS194046, novel pan-Janus kinase (JAK) inhibitor, shows inhibitory effects on T2 allergic lung inflammation in rats. In this work we analyze the of fluticasone propionate their combination neutrophils from non-T2 COPD patients vitro. Neutrophils 23 healthy subjects, 21 were incubated LAS194046 (0.01 nM-1 µM), (0.1 µM) or stimulated...

10.1038/s41598-022-09241-6 article EN cc-by Scientific Reports 2022-03-24

Abstract Background Several clinical studies have shown that smoking in asthmatics and chronic obstructive pulmonary disease patients is closely associated with corticosteroid refractoriness. In this work, we analyzed glucocorticoid insensitivity human artery endothelial cells ( HPAEC s) under cigarette smoke extract CSE ) exposure as well the possible additive effects of combination therapy a phosphodiesterase PDE )‐4 inhibitor. Methods Interleukin IL )‐8 was measured cell supernatants by...

10.1111/all.12055 article EN Allergy 2012-11-05
Coming Soon ...